About MUSC Hollings Cancer Center
Groundbreaking research to save lives
Our mission at MUSC Hollings Cancer Center is to eradicate cancer. It’s a bold mission, we know. We also know the toll cancer takes each year on our state’s residents. There will be an estimated 33,890 cases in 2023, with more than 11,000 deaths.
Hollings is the only National Cancer Institute-designated cancer center in the state. As the largest academic-based cancer research program in South Carolina, we are at the forefront of cancer research. We are also part of a network of 72 designated centers across the nation collaborating to accelerate scientific discoveries and offer cancer patients more and better treatment options.
With more than 130 cancer scientists across 20 different academic departments, Hollings provides a collaborative research environment focused on the causes, prevention, and treatment of cancer. We have experts known nationwide in a wide variety of fields from immunotherapy to health disparities. Hollings has an annual research funding portfolio of more than $44 million and over 200 clinical trials so that this research gets into the clinic to help cancer patients.
Providing quality, patient-centered care is part of our mission
It’s one reason U.S. News & World Report named MUSC Health University Medical Center as a high performing hospital for cancer care in its latest rankings. We have an award-winning bone marrow and stem cell transplant program, and MUSC Shawn Jenkins Children’s Hospital has a floor dedicated to cancer care for children.
I love the fact that we are able to cycle and pedal to raise dollars for cancer research and really make a difference in cancer care. We are trying to get more people on the bike and impact the community and ride with us for this very important effort. Together we can make a difference in cancer care.